UK Markets closed

Valbiotis SA (ALVAL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
5.06+0.06 (+1.20%)
At close: 04:52PM CEST
Full screen
Previous close5.00
Open5.04
Bid0.00 x 0
Ask0.00 x 0
Day's range4.98 - 5.06
52-week range4.01 - 7.45
Volume1,904
Avg. volume3,723
Market cap49.03M
Beta (5Y monthly)0.64
PE ratio (TTM)N/A
EPS (TTM)-0.51
Earnings date30 Sept 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.38
  • Business Wire

    Valbiotis Presents Additional Positive Results from the HEART Clinical Study on TOTUM•070 for Hypercholesterolemia

    LA ROCHELLE, France, October 03, 2022--Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, presents additional positive results from the Phase II HEART clinical study with TOTUM•070 for hypercholesterolemia. In the commercially targeted population with cholesterol levels above 130 mg/dl at randomization, TOTUM•070 reduced blood L

  • Business Wire

    Valbiotis Provides an Update on Its Progress and Publishes Its Financial Report for the First Half of 2022

    LA ROCHELLE, France, September 15, 2022--Regulatory News: Valbiotis (FR0013254851 – ALVAL / PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces its results for the first half of 2022 and provides an update on its developments since the beginning of the year.

  • Business Wire

    Frédéric PELONG, Chief Financial Officer, Joins the Valbiotis Board of Directors

    LA ROCHELLE, France, September 06, 2022--Regulatory News: Valbiotis (FR0013254851 - ALVAL, PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces the appointment of Frédéric PELONG to the Company’s Board of Directors.